annual review

Pfizer’s Three Virtues Initiative Strives to Transform African American Health and Wellness

Article

African Americans are disproportionately affected by many diseases and Pfizer is committed to improving health among this segment of the population through science, partnerships, insights and expertise.

Three Virtues is our integrated, enterprise-wide initiative aiming to:

Pfizer’s Vaccine Research & Development Program Applies Transformative Science to Help Protect People of All Ages

Article

At Pfizer, we discover and develop novel vaccines that help protect people around the world from deadly viruses and bacteria. In 2018, we focused on rational vaccine design — understanding the structure of proteins enabled by high-tech tools like cryo-electron microscopy as a basis to design and produce those proteins for use in vaccines.

Pfizer Utilizes Framework to Enable Quicker, More Effective Response to Major Societal Issues

Article

We live in challenging, often contentious times, with political, cultural and environmental issues constantly brewing. Companies across industries face the daunting task of appropriately responding to issues and news on a regular basis, and to help guide our responses at Pfizer, we developed our Social Framework – a way to determine if, when, how and why we will address a societal issue.

Pfizer Reaffirms Commitment to Delivering Essential Therapies Through Manufacturing Investment

Article

We are experiencing an exciting new era in drug discovery and development with scientific advances that could result in future breakthroughs. To make this promise a reality, Pfizer is dedicated to investing in manufacturing capabilities to keep pace with science today, and to plan for what’s coming next.

Pfizer Releases 2018 Annual Review

Article

Today, Pfizer released the 2018 Annual Review highlighting the ways that patients are the driving force behind every aspect of the company’s business in its mission to deliver innovative medicines and vaccines that help improve health and well-being at every stage of life.

This year, the integrated report explores how Pfizer’s work keeps Patients at Our Center. Highlights include:

Using the Science of Partnerships to Drive Patient Impact

Multimedia with summary

In Africa, patients can outnumber doctors 3,000 to 1. That’s one of the reasons why Pfizer is dedicated to fostering innovative partnerships that allow us to mobilize resources to help find new and unique solutions that increase access to needed health care.

Our colleague Willy Soriney, Strategic Partnership Director, works in Kenya using the science of partnerships to look for new approaches that can speed access to critical health interventions and fill unmet medical needs, bringing quality health care to those who need it most.

Tackling Antimicrobial Resistance with The Power of Science

Multimedia with summary

Antimicrobial resistance (AMR), or the ability of a bacterium, virus, or fungus to develop resistance to the medicines commonly used to treat them, is one of the leading global public health threats today. Currently, AMR causes more than 700,000 deaths annually. If left unchecked, this number is expected to rise to 10 million deaths annually by 2050. In collaboration with the infectious disease community, we are working to develop solutions that address and help treat the serious and growing AMR crisis.

Advancing The Power of Science Behind Immuno-Oncology

Multimedia with summary

Pfizer’s advances in oncology demonstrate the Power of Scientific innovation to help improve lives, particularly the power of Immuno-oncology (I-O). Immuno-oncology uses the natural ability of the body’s immune system to recognize and fight tumors. This past year, Pfizer continued to advance its work in I-O because we recognize the urgency of finding anti-cancer alternatives to help patients who need them.

Giving Millions a Shot

Blog

We are proud to work with Gavi, the Vaccine Alliance and the United Nations' (UN) Shot@Life campaign to ensure Pfizer’s life-saving vaccines reach those who need them most.

Using the Power of Partnerships to Support Global Goal 5: Gender Equality

Multimedia with summary

At Pfizer, we are proud to support the United Nations Sustainable Development Goals (SDGs), specifically Goal 5: Gender Equality. Equality across genders is fundamental to advancing all 17 of the SDGs, which in turn is connected to advancing global health.

This year and every year, Pfizer harnesses the power of partnerships with various organizations to help empower and mobilize women in need. 

Pages

Subscribe to annual review